NEW YORK, April 21 (Reuters) - Schering-Plough Corp (SGP.N), which Merck & Co (MRK.N) is in the process of acquiring, reported higher-than expected first-quarter earnings on Tuesday as the drugmaker cut costs.
NEW YORK, April 21 (Reuters) - Schering-Plough Corp (SGP.N), which Merck & Co (MRK.N) is in the process of acquiring, reported higher-than expected first-quarter earnings on Tuesday as the drugmaker cut costs.